Rationale: It has been reported that interleukin (IL)-1 is associated with pathological cardiac remodeling and LV dilatation, whereas IL-1 has also been shown to induce cardiomyocyte hypertrophy. Thus, the role of IL-1 in the heart remains to be determined. Objective: We studied the role of hypertrophy signal-mediated IL-1/insulin-like growth factor (IGF)-1 production in regulating the progression from compensative pressure-mediated hypertrophy to heart failure. Methods and Results: Pressure overload was performed by aortic banding in IL-1-deficient mice. Primarily cultured cardiac fibroblasts (CFs) and cardiac myocytes (CMs) were exposed to cyclic stretch. Heart weight, myocyte size, and left ventricular ejection fraction were significantly lower in IL-1-deficient mice (20%, 23% and 27%, respectively) than in the wild type 30 days after aortic banding, whereas interstitial fibrosis was markedly augmented. DNA microarray analysis revealed that IGF-1 mRNA level was markedly (Ϸ50%) decreased in the IL-1-deficient hypertrophied heart. Stretch of CFs, rather than CMs, abundantly induced the generation of IL-1 and IGF-1, whereas such IGF-1 induction was markedly decreased in IL-1-deficient CFs. IL-1 released by stretch is at a low level unable to induce IL-6 but sufficient to stimulate IGF-1 production. Promoter analysis showed that stretch-mediated IL-1 activates JAK/STAT to transcriptionally regulate the IGF-1 gene. IL-1 deficiency markedly increased c-Jun N-terminal kinase (JNK) and caspase-3 activities and enhanced myocyte apoptosis and fibrosis, whereas replacement of IGF-1 or JNK inhibitor restored them. Conclusions: We demonstrate for the first time that pressure-mediated hypertrophy and mechanical stretch generates a subinflammatory low level of IL-1, which constitutively causes IGF-1 production to maintain adaptable compensation hypertrophy and inhibit interstitial fibrosis. (Circ Res. 2009;105:1149-1158.)Key Words: interleukin-1 Ⅲ insulin-like growth factor-1 Ⅲ Akt Ⅲ JNK Ⅲ hypertrophy C ardiac hypertrophy is defined by augmentation of the ventricular mass against hemodynamic loads and upregulates contractile capacity and reduces ventricular wall stress, 1 whereas the capacity of this compensation is limited, and stronger and longer pressure overload induces pathological cardiac remodeling with left ventricular (LV) dilatation. 1 Pathological cardiac remodeling is associated with production of the extracellular matrix and causes increased signals of myocyte apoptosis. 2 Receptor tyrosine kinase, such as insulin-like growth factor (IGF)-1 receptor is involved in not only physiological hypertrophy 3 but also compensated hypertrophy after pressure overload. 4 IGF-1 promotes myocardial hypertrophy by activating phosphatidylinositol 3-kinase (PI3K) and its downstream effector Akt. 5,6 In addition, mitogenactivated protein kinase 7 acts as downstream molecules to promote hypertrophy.Overexpression of G protein-coupled 7-transmembrane receptors in the heart induced cardiac remodeling, resulting in he...
Background-Aldosterone has recently attracted considerable attention for its involvement in the pathophysiology of heart failure, in which apoptotic cell loss plays a critical role. This study examined whether aldosterone directly induces myocyte apoptosis via its specific receptors. Methods and Results-Neonatal rat cardiac myocytes were exposed to aldosterone (10 Ϫ8 to 10 Ϫ5 mol/L). Nuclear staining with Hoechst 33258 showed that aldosterone induced myocyte apoptosis in a dose-and time-dependent fashion. Treatment of myocytes with 10 Ϫ5 mol/L aldosterone significantly increased the percentage of apoptosis (15.5Ϯ1.4%) compared with serum-deprived control (7.3Ϯ0.6%). Radio ligand binding assay revealed the existence of plasma membrane receptor with high affinity (K d , 0.2 nmol/L) for aldosterone in cardiac myocytes but not in fibroblasts. Aldosterone rapidly (Ϸ30 seconds) mobilized [Ca 2ϩ ] i that was blocked by neomycin. Aldosterone induced dephosphorylation of the proapoptotic protein Bad, enhancement of mitochondrial permeability transition, decrease in mitochondrial membrane potential, and release of cytochrome c from the mitochondria into the cytosol with concomitant activation of caspase-3. These effects of aldosterone were inhibited by concurrent treatment with either an L-type Ca
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.